Gastric Polyps in a Patient With Dyspepsia.

Gastroenterology

Department of Internal Medicine and Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota. Electronic address:

Published: June 2022

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2022.02.043DOI Listing

Publication Analysis

Top Keywords

gastric polyps
4
polyps patient
4
patient dyspepsia
4
gastric
1
patient
1
dyspepsia
1

Similar Publications

The rare gastrointestinal tract epithelial polyp known as a pyloric gland adenoma (PGA) is more common in elderly women and uncommon in the duodenum. There are reports of two PGA cases involving high-grade intraepithelial neoplasia. A 75-year-old man was admitted to the hospital as Patient 1 due to "epigastric distension and pain for more than 10 days".

View Article and Find Full Text PDF

A case of Gastric cystic polyp mimicking early gastric cancer.

J Gastrointestin Liver Dis

December 2024

Department of Gastroenterology and Hepatology, West China Tianfu Hospital, Sichuan University, Chengdu, Sichuan Province; Department of Gastroenterology and Hepatology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.

In this study, we present a case of a 51-year-old man with a gastric lesion initially suspected to be early gastric cancer but was ultimately diagnosed as a Gastric cystic polyp (GCP). The patient underwent diagnostic endoscopic submucosal dissection (ESD) based on the lesion's appearance and characteristics. Detailed pathological and immunohistochemical analysis confirmed the diagnosis of GCP.

View Article and Find Full Text PDF

Fibrovascular polyps are rare, pedunculated, tumor-like lesions usually found in the esophagus. Their occurrence in the stomach is exceedingly rare. In the literature review, several case reports documented fibrovascular polyps developing in the stomach.

View Article and Find Full Text PDF

Background: Capecitabine, a prodrug of 5-fluorouracil, is extensively utilized for the treatment of metastatic breast cancer, colorectal cancer, and gastric cancer. Nevertheless, there exist limitations in comprehending adverse reactions (AEs) in clinical practice. In this study, we investigated the distribution of AEs associated with capecitabine and explored potential rare adverse reactions by mining the Food and Drug Administration Adverse Event Reporting System (FAERS).

View Article and Find Full Text PDF

Vonoprazan is a novel acid blocker with greater potency than proton pump inhibitors. A Japanese study reported no significant safety concerns over 5 years of Vonoprazan use; however, elevated serum gastrin and increased parietal cell and foveolar hyperplasia were observed, and long-term safety data beyond 5 years are limited. We report a case that used Vonoprazan for 6 years, complicated by significant gastric epithelial changes during treatment and acute duodenal mucosal lesions following its discontinuation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!